Jan Heidemann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jan Heidemann has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Dominik Bettenworth
Department of Medicine B, University Hospital Münster, Münster, Germany
10 shared publications Andreas Luegering
6 shared publications- Tobias Max Nowacki
Department of Medicine B for Gastroenterology, Hepatology, Endocrinology and Clinical Infectiology, University Hospital Muenster, 48149 Muenster, Germany
6 shared publications - Matthias Ross
Department of Medicine B, University of Münster, Münster 48149, Germany
4 shared publications Wolfram W. Domschke
4 shared publications- Markus Brückner
Department of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, D-48149 Münster, Germany
3 shared publications
Latest Publications
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Tu1888 Protective Role of Sydecan-4 in Experimental Colitis
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Tu1888 Protective Role of Sydecan-4 in Experimental Colitis
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo1799 Targeting Endovascular Adhesion Molecules With Ultrasound Contrast Agent In Vivo to Characterize Murine DSS-Colitis in Mice
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo1799 Targeting Endovascular Adhesion Molecules With Ultrasound Contrast Agent In Vivo to Characterize Murine DSS-Colitis in Mice
- Open Access
Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
The role of cytomegalovirus (CMV) infection in the pathogenesis and exacerbation of Inflammatory Bowel Disease (IBD) has been unresolved. Typically, the CMV genome remains dormant in infected cells, but a breakdown of immune surveillance can lead to re-activation of viral replication in the gut mucosa, which is not necessarily associated with viremia or changes in antibody titers. We hypothesized that the detection of CMV-specific CD8 effector T cells should permit the distinction between dormant and active CMV infection. As CD8 effector T cells, unlike memory CD8 T cells, have perforin (PFN) and granzyme B (GzB) preformed in their cytoplasmic granules, we employed single cell resolution ELISPOT assays to measure the CMV antigen-triggered release of these molecules by CD8 T cells isolated from subjects with IBD, and age-matched healthy controls. The frequencies of CMV-specific (GzB) and PFN-producing CD8 T cells were increased in IBD patients compared to healthy controls. Furthermore, the increased CMV reactivity was associated with active IBD disease and with longer disease duration. Notably, PCR on serum frequently failed to detect CMV DNA during flares. The data show that during active IBD there is a flare of CD8 T cell activity against CMV in a substantial proportion of IBD patients, suggesting CMV reactivation that serum PCR does not detect. While it remains open whether CMV reactivation is a cause or consequence of IBD, our data suggest that monitoring CMV antigen-specific effector CD8 T cells with GzB and PFN ELISPOT analysis can provide novel insights into the role of CMV infection in IBD. Additionally, our data have implications for the fields of transplantation, HIV, cancer, and autoimmune diseases, in all of which patient care critically depends on sensitive and reliable detection of a reactivation of CMV infection.
Open AccessCytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
The role of cytomegalovirus (CMV) infection in the pathogenesis and exacerbation of Inflammatory Bowel Disease (IBD) has been unresolved. Typically, the CMV genome remains dormant in infected cells, but a breakdown of immune surveillance can lead to re-activation of viral replication in the gut mucosa, which is not necessarily associated with viremia or changes in antibody titers. We hypothesized that the detection of CMV-specific CD8 effector T cells should permit the distinction between dormant and active CMV infection. As CD8 effector T cells, unlike memory CD8 T cells, have perforin (PFN) and granzyme B (GzB) preformed in their cytoplasmic granules, we employed single cell resolution ELISPOT assays to measure the CMV antigen-triggered release of these molecules by CD8 T cells isolated from subjects with IBD, and age-matched healthy controls. The frequencies of CMV-specific (GzB) and PFN-producing CD8 T cells were increased in IBD patients compared to healthy controls. Furthermore, the increased CMV reactivity was associated with active IBD disease and with longer disease duration. Notably, PCR on serum frequently failed to detect CMV DNA during flares. The data show that during active IBD there is a flare of CD8 T cell activity against CMV in a substantial proportion of IBD patients, suggesting CMV reactivation that serum PCR does not detect. While it remains open whether CMV reactivation is a cause or consequence of IBD, our data suggest that monitoring CMV antigen-specific effector CD8 T cells with GzB and PFN ELISPOT analysis can provide novel insights into the role of CMV infection in IBD. Additionally, our data have implications for the fields of transplantation, HIV, cancer, and autoimmune diseases, in all of which patient care critically depends on sensitive and reliable detection of a reactivation of CMV infection.
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Disease Activity Assessment of Murine DSS-Colitis by 18F-FDG-PET/CT
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Disease Activity Assessment of Murine DSS-Colitis by 18F-FDG-PET/CT
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
ApoA-I Mimetic 5a Peptide Exerts Potent Anti-Inflammatory Effects In Vivo and In Vitro and Ameliorates Experimental DSS Colitis
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
ApoA-I Mimetic 5a Peptide Exerts Potent Anti-Inflammatory Effects In Vivo and In Vitro and Ameliorates Experimental DSS Colitis
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Ultrasonographic Characterization of Murine DSS-Colitis – 40 Mhz In Vivo Hydrosonography Monitors Features of Colonic Inflammation in Mice
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Ultrasonographic Characterization of Murine DSS-Colitis – 40 Mhz In Vivo Hydrosonography Monitors Features of Colonic Inflammation in Mice
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5)
S1770 Induction of a Fatal Course of a Citrobacter rodentium Induced Infectious Colitis by Depletion of Regulatory T Cells
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5)
S1770 Induction of a Fatal Course of a Citrobacter rodentium Induced Infectious Colitis by Depletion of Regulatory T Cells
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5)
M1741 Transporter Mediated Uptake of Melanocortin-Derived Tripeptide K(D)PT Improves Intestinal Barrier Function
- 31 May 2010
- Published by Elsevier in Gastroenterology
- Vol. 138 (5)
M1741 Transporter Mediated Uptake of Melanocortin-Derived Tripeptide K(D)PT Improves Intestinal Barrier Function
- 31 May 2009
- Published by Elsevier in Gastroenterology
- Vol. 136 (5) , A-240-240
S1642 New Tools for In Vivo Imaging of Murine DSS-Colitis - Mrp14-Directed Fluorescence-Mediated Molecular Tomography (FMT) and High-Resolution Ultrasound Imaging
- 31 May 2009
- Published by Elsevier in Gastroenterology
- Vol. 136 (5) , A-240-240
S1642 New Tools for In Vivo Imaging of Murine DSS-Colitis - Mrp14-Directed Fluorescence-Mediated Molecular Tomography (FMT) and High-Resolution Ultrasound Imaging